MicroBase Technology

MicroBase Technology Change in Working Capital

The Change in Working Capital of MicroBase Technology (3184.TWO) as of Nov 5, 2026 is -6.98 M TWD. In the previous year, Change in Working Capital was -12.46 M TWD — a change of -44.01% (higher).

Change in Working Capital

-6.98 MTWD

YoY

-44.01%

Last updated:

Change in Working Capital of MicroBase Technology is 2025 -6.98 M TWD. Change in Working Capital of MicroBase Technology was 2024 -12.46 M TWD. It decreases by -44.01% higher compared to the previous year.

The MicroBase Technology Change in Working Capital history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Change in Working Capital
Date
Change in Working Capital
Jan 1, 2017
-21.18 M TWD
Jan 1, 2018
-23.69 M TWD
Jan 1, 2020
6.06 M TWD
Jan 1, 2021
28.57 M TWD
Jan 1, 2022
15.37 M TWD
Jan 1, 2023
-8.39 M TWD
Jan 1, 2024
-12.46 M TWD
Jan 1, 2025
-6.98 M TWD
The MicroBase Technology Change in Working Capital history
YEARChange in Working CapitalYoY
-6.98 MTWD-44.01%
-12.46 MTWD+48.49%
-8.39 MTWD-154.60%
15.37 MTWD-46.18%
28.57 MTWD+371.15%
6.06 MTWD-125.60%
-23.69 MTWD+11.84%
-21.18 MTWD+10,230.73%
-205,000.00TWD-97.43%
-7.97 MTWD-203.08%
7.73 MTWD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

MicroBase Technology Stock analysis

What does MicroBase Technology do? MicroBase Technology Corp, listed on the Taiwan Stock Exchange under ticker 3184.TWO, is a health care company headquartered in Taoyuan, Taiwan. The company has 48 employees and completed its initial public offering on April 18, 2013. MicroBase Technology Corp engages in the production, planning, and maintenance of medical equipment. The company's product portfolio includes the Inkjet Printer Nozzle Plate, Microneedle Patch, Aerosol Generator Head, Nebulizer, and Soft Mist Inhaler, among others. These products are distributed both domestically within Taiwan and internationally to overseas markets. The company operates within the health care sector, focusing on medical equipment solutions. MicroBase Technology Corp maintains a website at https://microbasetech.com/ for further information. The company's operations are centered around the development and distribution of specialized medical devices, with an emphasis on both local and global market reach. As a publicly traded entity, it provides transparency through its financial disclosures and corporate governance practices. The firm's activities are primarily conducted in Taoyuan, Taiwan, reflecting its regional operational base. MicroBase Technology Corp's business model involves the manufacturing and maintenance of medical equipment, targeting both domestic and international customers through its product offerings. MicroBase Technology is one of the most popular companies on Eulerpool.

Frequently Asked Questions about MicroBase Technology stock

Change in Working Capital of MicroBase Technology is -6.98 M TWD in 2025.

Change in Working Capital of MicroBase Technology changed from -12.46 M TWD to -6.98 M TWD, representing a -44.01% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Change in Working Capital MicroBase Technology since 2006 – with annual values, charts, and detailed analysis.

Change in working capital reflects the period-over-period change in current assets minus current liabilities. It impacts operating cash flow significantly.

Change in Working Capital's TWD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Change in Working Capital's MicroBase Technology historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — MicroBase Technology

All Key Metrics — MicroBase Technology